Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,591.20
(
0.01%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
104.16
(
0.45%
)
Bitcoin
79,564.94
(
0.35%
)
News Focus
News Focus
Post# of 257556
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 140287

Tuesday, 02/12/2013 9:24:57 PM

Tuesday, February 12, 2013 9:24:57 PM

Post# of 257556
According to Celltrion/HSP information you furnished, there are eight FoB’s in the collaboration: Remicade, Herceptin, Rituxan, Enbrel, Erbitux, Synagis, Humira, and Avastin: see page 9 of https://dl.dropbox.com/u/72115812/celltrion_kdb_report_04JAN2012.pdf .

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today